PSNC has updated its Electronic Repeat Dispensing (eRD) webpage and guidance. The updated webpage explains how the eRD process works and contains useful resources for pharmacy and general practice teams. The webpage also includes resources to support with the promotion of eRD to patients, a list of frequently asked questions and links to external resources [...]
The post New Electronic Repeat Dispensing guidance appeared first on PSNC Website.
National Patient Safety Alert: Class 1 Medicines Recall Notification: Recall of Targocid 200mg powder for solution for injection/infusion or oral solution, Aventis Pharma Limited t/a Sanofi, due to the presence of bacterial endotoxins. National Patient Safety Alert Reference Number: NatPSA/2022/008/MHRA Date issued: 21st October 2022 Targocid 200mg powder for solution for injection/infusion or oral solution [...]
The post National Patient Safety Alert: Class 1 Medicines Recall Notification: Targocid 200mg powder for solution for injection/infusion or oral solution appeared first on PSNC Website.
Drug alert number: EL(22)A/44 Date issued: 20 October 2022 The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 2 medicines recall for: Ephedrine Hydrochloride 30 mg/ml Solution for Injection – hameln pharma ltd PL 01502/0103 Batch Number Expiry Date Pack Size First Distributed 11081120C 11/ 2023 10 x 1 ml 14/06/2021 04600520C [...]
The post MHRA Class 2 Medicines Recall: Ephedrine Hydrochloride 30 mg/ml Solution for Injection appeared first on PSNC Website.
Community pharmacy contractors have two weeks left to claim an Aspiration payment for the Pharmacy Quality Scheme (PQS) 2022/23 as the window for claiming this payment closes at 11.59pm on 4th November 2022. The Aspiration payment is optional; if contractors do not want to claim it, it will not impact on the contractor’s ability to claim [...]
The post PQS reminder: Two weeks left to claim Aspiration payment appeared first on PSNC Website.
Department of Health and Social Care (DHSC) has issued a medicine supply notification for Medroxyprogesterone (Provera®) 2.5mg and 10mg tablets. MSN/2022/074U Tier 3 – high impact Date of issue 20th October 2022 This is an update (changes in bold) to MSN/2022/074 Medroxyprogesterone (Provera®) 2.5mg tablets are out of stock until mid-November 2022 Intermittent supply of [...]
The post Medicine Supply Notification: Medroxyprogesterone (Provera®) 2.5mg and 10mg tablets appeared first on PSNC Website.
Recent Comments